Revenue
$45.2B
Gross Margin
+39.4%
Operating Margin
+17.8%
Net Margin
+15.2%
Income statement waterfall for Thermo Fisher Scientific (TMO) — TTM through Q1 2026
Net income: $6.86B
Margin breakdown for Thermo Fisher Scientific (TMO) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $45.2B | $45.2B |
| Cost of Revenue | -$27.4B | $17.8B |
| Gross Profit | $17.8B | $17.8B |
| Operating Expenses | -$9.79B | $8.03B |
| Operating Income | $8.03B | $8.03B |
| Other Income / Expense | -$629M | $7.4B |
| Pre-tax Income | $7.4B | $7.4B |
| Income Tax | -$522M | $6.87B |
| Net Income | $6.86B | $6.86B |
- Revenue$45.2B
- Cost of Revenue-$27.4B
- Gross Profit$17.8B
- Operating Expenses-$9.79B
- Operating Income$8.03B
- Other Income / Expense-$629M
- Pre-tax Income$7.4B
- Income Tax-$522M
- Net Income$6.86B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks4.54% TTM
- Dividend Profile0.34% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History8 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.